Acupuncture and Gabapentin for Hot Flashes Among Breast Cancer Survivors
Overall Objectives: The overarching goal is to compare the effectiveness of acupuncture and gabapentin to their respective placebo controls in the treatment of hot flashes in breast cancer patients. The investigators primary specific aim will focus on determining the magnitude of response to placebo acupuncture versus placebo pills on hot flashes (HFs).
Hot Flashes
DRUG: Gabapentin
Daily Hot Flash Diary (DHFD)-Primary Outcome (2 minutes per day), Daily starting from baseline until week 12 and again for one week at week 24.
Demographics -Covariates, 5 minutes|Hot Flash Related Daily Interference Scale (HFRDIS)-Secondary outcome, 3 minutes|Pittsburgh Sleep Quality Index (PSQI) - Secondary outcome, 6 minutes|Brief Fatigue Inventory (BFI) - Secondary Outcome, 3 minutes|HADS - Secondary Outcome, 2 minutes|Global Assessment Scale -Secondary Outcome, 30 seconds|Acupuncture Expectancy Scale (AES) - Secondary Aim, 1 minute|Creditability Rating of Acupuncture - Secondary Aim, 1 minute|Medication and CAM Usage -Covariates, 5 minutes|Actigraph Movement Measuring Device, 24 hrs/day for 3 days
Overall Objectives: The overarching goal is to compare the effectiveness of acupuncture and gabapentin to their respective placebo controls in the treatment of hot flashes in breast cancer patients. The investigators primary specific aim will focus on determining the magnitude of response to placebo acupuncture versus placebo pills on hot flashes (HFs).